News
Key Pancreatic Cancer Defect Is Identified by UCSF Researchers
Pancreatic cancer, compared to other types of leading cancer killers, is detected later and does not respond well to either new or established drugs. Now a new UC San Francisco study has shed light on the origins of one type of deadly pancreatic cancer. In a study published online February 23, 2014
CTSI Spotlight: Joel Palefsky
Joel Palefsky, MD, is the director of the Clinical and Translational Research Fellowship Program (CTRFP) at CTSI. Note: Dr. Palefsky was recently awarded an $89 million grant from the National Cancer Institute for a major investigation of anal cancer. How long have you worked at UCSF? I’ve been at
Dr. Frank E. Staggers Put 'Community' in Cancer Center Advisory Board
"You never said no to Dr. Staggers, because he never said no to the community." In 2005, Dr. Rena Pasick was set to establish a community advisory board for UCSF's Helen Diller Family Comprehensive Cancer Center as a matter of course. What ensued, however, was far from routine, thanks to Frank E
Margaret A. Tempero, MD, Named Editor-in-Chief of JNCCN
JNCCN - Journal of the National Comprehensive Cancer Network named Margaret A. Tempero, MD, UCSF Helen Diller Family Comprehensive Cancer Center, as the new Editor-in-Chief, succeeding Harold J. Burstein, MD, PhD, who served in the position for five years. "Dr. Tempero’s highly esteemed career and
UCSF Schools Lead the Nation in NIH Biomedical Research Funds
UC San Francisco’s four professional schools topped the nation in federal research funding in 2013, with the University as a whole ranking first among public recipients and second overall in funds from the National Institutes of Health (NIH), according to annual NIH figures. These highly competitive
Paradox of Cigarette Sales in Pharmacies Focus of New Movement
Pharmacies, focused on the health and wellbeing of their customers, have long been saddled with a paradox: they sell cigarettes and other tobacco products, even though tobacco use is the nation’s leading cause of preventable death. If retailers, particularly pharmacies, were to discontinue selling
Killing Cancer Through the Immune System (Part II)
continued from " Killing Cancer Through the Immune System," Feb 4, 2014, UCSF.edu “For the longest time, people did not believe this was possible,” said Lawrence Fong, MD, associate professor of medicine at UCSF and one of the University’s lead investigators in the expanding use of immunotherapy